Email Icon Facebook icon Twitter Icon GooglePlus Icon Contact

User Top Menu

A summary of the FDA-NIMH-MATRICS workshop on clinical trial design for neurocognitive drugs for schizophrenia.

Buchanan RW, Davis M, Goff D, Green MF, Keefe RSE, Leon AC, Nuechterlein KH, Laughren T, Levin R, Stover E, et al.
Schizophr Bull. 2005 Jan; 31(1):5-19. PMID: 15888422. Pubmed